Neuropsychiatric events following high-dose steroid administration during early immune checkpoint therapy are more frequent with extended steroid exposure

Patients on immune checkpoint therapy (ICT) are at risk for neuropsychiatric events due to the use of steroids in managing immune-related adverse effects. We aimed to characterize neuropsychiatric events after the initial administration of high-dose steroids following early ICT.

Saved in:
Bibliographic Details
Main Authors: Lacourt, Tamara E. (Author) , Schubert, Marc Cicero (Author) , Siddiqui, Bilal A. (Author) , Subudhi, Sumit K. (Author) , Chopra, Deepti A. (Author)
Format: Article (Journal)
Language:English
Published: 08 November 2025
In: Supportive care in cancer
Year: 2025, Volume: 33, Issue: 12, Pages: 1-9
ISSN:1433-7339
DOI:10.1007/s00520-025-10083-x
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00520-025-10083-x
Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.1007/s00520-025-10083-x?utm_source=getftr&utm_medium=getftr&utm_campaign=getftr_pilot&getft_integrator=clarivate
Get full text
Author Notes:Tamara E. Lacourt, Marc C. Schubert, Bilal A. Siddiqui, Sumit K. Subudhi, Deepti A. Chopra

MARC

LEADER 00000naa a2200000 c 4500
001 1962045366
003 DE-627
005 20260220134005.0
007 cr uuu---uuuuu
008 260220s2025 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00520-025-10083-x  |2 doi 
035 |a (DE-627)1962045366 
035 |a (DE-599)KXP1962045366 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Lacourt, Tamara E.  |e VerfasserIn  |0 (DE-588)1390845621  |0 (DE-627)196204565X  |4 aut 
245 1 0 |a Neuropsychiatric events following high-dose steroid administration during early immune checkpoint therapy are more frequent with extended steroid exposure  |c Tamara E. Lacourt, Marc C. Schubert, Bilal A. Siddiqui, Sumit K. Subudhi, Deepti A. Chopra 
264 1 |c 08 November 2025 
300 |b Diagramme 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 20.02.2026 
520 |a Patients on immune checkpoint therapy (ICT) are at risk for neuropsychiatric events due to the use of steroids in managing immune-related adverse effects. We aimed to characterize neuropsychiatric events after the initial administration of high-dose steroids following early ICT. 
650 4 |a Adverse events 
650 4 |a Cancer 
650 4 |a Corticosteroids 
650 4 |a Immunotherapy 
650 4 |a Neuropsychiatric 
650 4 |a Steroids 
700 1 |a Schubert, Marc Cicero  |e VerfasserIn  |0 (DE-588)1264158912  |0 (DE-627)1812829779  |4 aut 
700 1 |a Siddiqui, Bilal A.  |e VerfasserIn  |4 aut 
700 1 |a Subudhi, Sumit K.  |e VerfasserIn  |4 aut 
700 1 |a Chopra, Deepti A.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Supportive care in cancer  |d Berlin : Springer, 1993  |g 33(2025), 12, Artikel-ID 1031, Seite 1-9  |h Online-Ressource  |w (DE-627)254909574  |w (DE-600)1463166-0  |w (DE-576)074754076  |x 1433-7339  |7 nnas  |a Neuropsychiatric events following high-dose steroid administration during early immune checkpoint therapy are more frequent with extended steroid exposure 
773 1 8 |g volume:33  |g year:2025  |g number:12  |g elocationid:1031  |g pages:1-9  |g extent:9  |a Neuropsychiatric events following high-dose steroid administration during early immune checkpoint therapy are more frequent with extended steroid exposure 
856 4 0 |u https://doi.org/10.1007/s00520-025-10083-x  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext  |7 1 
856 4 0 |u https://link.springer.com/article/10.1007/s00520-025-10083-x?utm_source=getftr&utm_medium=getftr&utm_campaign=getftr_pilot&getft_integrator=clarivate  |x Verlag  |z lizenzpflichtig  |3 Volltext  |7 1 
951 |a AR 
992 |a 20260220 
993 |a Article 
994 |a 2025 
998 |g 1264158912  |a Schubert, Marc Cicero  |m 1264158912:Schubert, Marc Cicero  |d 50000  |e 50000PS1264158912  |k 0/50000/  |p 2 
999 |a KXP-PPN1962045366  |e 4920568738 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Tamara E. Lacourt, Marc C. Schubert, Bilal A. Siddiqui, Sumit K. Subudhi, Deepti A. Chopra"]},"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"08 November 2025"}],"note":["Gesehen am 20.02.2026"],"person":[{"family":"Lacourt","given":"Tamara E.","role":"aut","display":"Lacourt, Tamara E."},{"given":"Marc Cicero","family":"Schubert","display":"Schubert, Marc Cicero","role":"aut"},{"role":"aut","display":"Siddiqui, Bilal A.","given":"Bilal A.","family":"Siddiqui"},{"display":"Subudhi, Sumit K.","role":"aut","given":"Sumit K.","family":"Subudhi"},{"family":"Chopra","given":"Deepti A.","role":"aut","display":"Chopra, Deepti A."}],"relHost":[{"recId":"254909574","disp":"Neuropsychiatric events following high-dose steroid administration during early immune checkpoint therapy are more frequent with extended steroid exposureSupportive care in cancer","pubHistory":["1.1993 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"eki":["254909574"],"zdb":["1463166-0"],"issn":["1433-7339"]},"language":["eng"],"title":[{"subtitle":"official journal of the Multinational Association of Supportive Care in Cancer","title_sort":"Supportive care in cancer","title":"Supportive care in cancer"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"pages":"1-9","volume":"33","extent":"9","year":"2025","text":"33(2025), 12, Artikel-ID 1031, Seite 1-9","issue":"12"},"origin":[{"dateIssuedKey":"1993","publisherPlace":"Berlin ; Heidelberg ; New York,NY","dateIssuedDisp":"1993-","publisher":"Springer"}],"note":["Gesehen am 06.12.05"]}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1962045366","physDesc":[{"extent":"9 S.","noteIll":"Diagramme"}],"id":{"eki":["1962045366"],"doi":["10.1007/s00520-025-10083-x"]},"language":["eng"],"title":[{"title":"Neuropsychiatric events following high-dose steroid administration during early immune checkpoint therapy are more frequent with extended steroid exposure","title_sort":"Neuropsychiatric events following high-dose steroid administration during early immune checkpoint therapy are more frequent with extended steroid exposure"}]} 
SRT |a LACOURTTAMNEUROPSYCH0820